Will Safety Issues Derail Denosumab? FDA Sets Advisory Cmte. Slot

Amgen’s much-ballyhooed monoclonal antibody, now called Prolia, faces safety questions at the Aug. 13 Advisory Committee for Reproductive Health Drugs meeting.

More from Archive

More from Pink Sheet